Prostatis Group LLC Thermo Fisher Scientific Inc. Transaction History

Prostatis Group LLC

$215 Billion
Q2 2023

A detailed history of Prostatis Group LLC transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Prostatis Group LLC holds 1,452,094 shares of TMO stock, worth $745 Million. This represents 0.69% of its overall portfolio holdings.

Number of Shares

1,452,094

Previous 2,824 51319.76%

Holding current value

$745 Million

Previous $1.63 Billion 9.38%

% of portfolio

0.69%

Previous 0.86%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$508.46 - $591.13 $737 Million - $857 Million	1,449,270 Added 51319.76%	1,452,094 $1.47 Billion
Q1 2023 May 22, 2023	SELL	$535.0 - $604.82 $1,070 - $1,209	-2 Reduced 0.07%	2,824 $1.63 Billion
Q4 2022 Mar 28, 2023	SELL	$484.71 - $571.37 $619,459 - $730,210	-1,278 Reduced 31.14%	2,826 $1.56 Billion
Q4 2022 Mar 23, 2023	SELL	$484.71 - $571.37 $251 Million - $295 Million	-516,995 Reduced 25.22%	1,532,626 $1.56 Billion
Q3 2022 Mar 28, 2023	BUY	$507.19 - $604.49 $605,077 - $721,156	1,193 Added 40.98%	4,104 $2.08 Billion
Q3 2022 Mar 23, 2023	BUY	$507.19 - $604.49 $248 Million - $296 Million	489,824 Added 31.4%	2,049,621 $2.08 Billion
Q2 2022 Mar 28, 2023	SELL	$500.9 - $612.21 $716,787 - $876,072	-1,431 Reduced 32.96%	2,911 $1.58 Billion
Q2 2022 Mar 23, 2023	SELL	$500.9 - $612.21 $429 Million - $525 Million	-857,239 Reduced 35.47%	1,559,797 $1.58 Billion
Q1 2022 Mar 28, 2023	BUY	$524.0 - $644.92 $78,076 - $96,093	149 Added 3.55%	4,342 $2.56 Billion
Q1 2022 Mar 23, 2023	SELL	$524.0 - $644.92 $160 Million - $197 Million	-304,750 Reduced 11.2%	2,417,036 $2.56 Billion
Q4 2021 Mar 28, 2023	BUY	$569.0 - $667.24 $569,000 - $667,240	1,000 Added 31.32%	4,193 $2.8 Billion
Q4 2021 Mar 23, 2023	BUY	$569.0 - $667.24 $520 Million - $610 Million	914,069 Added 50.56%	2,721,786 $2.8 Billion
Q3 2021 Mar 28, 2023	BUY	$509.53 - $609.78 $186,997 - $223,789	367 Added 12.99%	3,193 $1.82 Billion
Q3 2021 Mar 23, 2023	BUY	$509.53 - $609.78 $108 Million - $129 Million	211,545 Added 13.25%	1,807,717 $1.82 Billion
Q2 2021 Mar 28, 2023	BUY	$441.0 - $508.24 $1,764 - $2,032	4 Added 0.13%	3,193 $1.61 Billion
Q2 2021 Mar 23, 2023	BUY	$441.0 - $508.24 $67.1 Million - $77.3 Million	152,161 Added 10.54%	1,596,172 $1.61 Billion
Q1 2021 Mar 28, 2023	BUY	$439.85 - $518.83 $7,477 - $8,820	17 Added 0.54%	3,189 $1.46 Billion
Q1 2021 Mar 23, 2023	SELL	$439.85 - $518.83 $13.1 Million - $15.4 Million	-29,725 Reduced 2.02%	1,444,011 $1.46 Billion
Q4 2020 Mar 28, 2023	SELL	$435.06 - $527.66 $282,353 - $342,451	-649 Reduced 16.99%	3,172 $1.48 Billion
Q4 2020 Mar 23, 2023	SELL	$435.06 - $527.66 $91.3 Million - $111 Million	-209,788 Reduced 12.46%	1,473,736 $1.48 Billion
Q3 2020 Mar 28, 2023	SELL	$359.77 - $441.52 $2,158 - $2,649	-6 Reduced 0.16%	3,821 $1.69 Billion
Q3 2020 Mar 23, 2023	BUY	$359.77 - $441.52 $107 Million - $131 Million	296,849 Added 21.41%	1,683,524 $1.69 Billion
Q2 2020 Mar 28, 2023	SELL	$275.2 - $362.34 $645,894 - $850,411	-2,347 Reduced 38.01%	3,827 $1.39 Billion
Q2 2020 Mar 23, 2023	BUY	$275.2 - $362.34 $83.4 Million - $110 Million	302,947 Added 27.95%	1,386,675 $1.39 Billion
Q1 2020 Mar 28, 2023	SELL	$255.3 - $340.05 $139,904 - $186,347	-548 Reduced 8.15%	6,174 $1.75 Billion
Q1 2020 Mar 23, 2023	SELL	$255.3 - $340.05 $40.3 Million - $53.7 Million	-157,910 Reduced 12.72%	1,083,728 $1.75 Billion
Q4 2019 Mar 28, 2023	SELL	$271.93 - $328.04 $415 Million - $501 Million	-1,525,904 Reduced 99.56%	6,722 $2.18 Billion
Q4 2019 Mar 23, 2023	BUY	$271.93 - $328.04 $338 Million - $407 Million	1,241,638 New	1,241,638 $2.18 Billion

Others Institutions Holding TMO

# of Institutions

2,829

Shares Held

334M

Call Options Held

2.37M

Put Options Held

2.75M

View Full List

About THERMO FISHER SCIENTIFIC INC.

Ticker TMO
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 391,788,992
Market Cap $201B
Description
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...

More about TMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prostatis Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prostatis Group LLC with notifications on news.

Account

Prostatis Group LLC Thermo Fisher Scientific Inc. Transaction History